Finally, in three breast cancer cell lines enriched for cancer stem cells by growing them as mammospheres, the compound acted through upregulation of the Wnt antagonists sFRP4 and DKK1, which made the cells more susceptible to apoptosis caused by specific ROS induction by the compound treatment, as activation of the pathway would help them resist [76]. Here, DKK1 is linked to cancer.